Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Proschan

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 25, 2011
CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7Marta Catalfamo, Christopher Wilhelm, Lueng Tcheung, et al.
Hepatology International|November 28, 2015
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a studyTess Petersen, Kerry Townsend, Lori A Gordon, et al.
Clinical Trials (London, England)|July 18, 2020
Endpoints for randomized controlled clinical trials for COVID-19 treatmentsLori E Dodd, Dean Follmann, Jing Wang, et al.
Science Translational Medicine|November 29, 2019
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groupsLori E Dodd, Dean Follmann, Michael Proschan, et al.
Circulation|May 3, 2006
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialBarry R Davis, Linda B Piller, Jeffrey A Cutler, et al.
Lancet (London, England)|March 19, 2013
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysisDaniel A Salmon, Michael Proschan, Richard Forshee, et al.
The Journal of Infectious Diseases|May 23, 2020
Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral TherapyMichael C Sneller, Erin D Huiting, Katherine E Clarridge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2015
Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral TherapyCaryn G Morse, Mary McLaughlin, Lindsay Matthews, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patientsVeronique Nussenblatt, Mary McLaughlin, Catherine A Rehm, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Richard H. Grimm, Karen L. Margolis, Vasilios Papademetriou, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|January 25, 2011
CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7Marta Catalfamo, Christopher Wilhelm, Lueng Tcheung, et al.
Hepatology International|November 28, 2015
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a studyTess Petersen, Kerry Townsend, Lori A Gordon, et al.
Clinical Trials (London, England)|July 18, 2020
Endpoints for randomized controlled clinical trials for COVID-19 treatmentsLori E Dodd, Dean Follmann, Jing Wang, et al.
Science Translational Medicine|November 29, 2019
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groupsLori E Dodd, Dean Follmann, Michael Proschan, et al.
Circulation|May 3, 2006
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialBarry R Davis, Linda B Piller, Jeffrey A Cutler, et al.
Lancet (London, England)|March 19, 2013
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysisDaniel A Salmon, Michael Proschan, Richard Forshee, et al.
The Journal of Infectious Diseases|May 23, 2020
Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral TherapyMichael C Sneller, Erin D Huiting, Katherine E Clarridge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2015
Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral TherapyCaryn G Morse, Mary McLaughlin, Lindsay Matthews, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patientsVeronique Nussenblatt, Mary McLaughlin, Catherine A Rehm, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Richard H. Grimm, Karen L. Margolis, Vasilios Papademetriou, et al.
Pageof 6